misiu143 - "We must be with a big company not afraid of Gilead , or start in other countries.." -- if shareholders haven't already understood this, then I don't know what to say. IMO, it's 1:100 odds that CYDY gets approval on it's own. We can save lives easier, quicker, if this molecules partners, BO into 'established' hands. Reason why I dont think licensing, IMHO isn't on the table is, it still gives CYDY room to grow. The pharma industry doesn't want CYDY to grow...
ALL IMHO.
GLTU/A.
Market Data 
Markets 
AI
